BASF Future Business GmbH and Medi-Solve Coatings LLC have announced a collaboration in the field of antimicrobial coatings for catheters and other minimally invasive medical devices. This collaboration combines Medi-Solve’s proprietary AquaCoat® coating technology with BASF Future Business’ proprietary HyGentic® silver- based antimicrobial additive platform. Medical device manufacturers will benefit from the enhanced safety and performance of these customized multi-functional coating solutions developed through this collaboration. Both companies will be presenting their respective portfolios at the Medical Design & Manufacturing (MD&M) West Show in Anaheim, California, Feb. 8-10, 2011.
BASF Future Business GmbH opens up new business opportunities for BASF, the Chemical Company. "In the area of medical devices materials, we are expanding our offering by developing enabling solutions for our customers in partnership with highly innovative companies such as Medi-Solve Coatings LLC," said Stefan Becker, Senior Manager, BASF Future Business GmbH. "Medi-Solve brings many years of experience in medical device coatings to this collaboration and we are excited to work with their team. New functional materials for medical applications not only improve the standard of medical care for an aging population, but also address important economic needs, such as the cost pressure in the healthcare system," he added.
"Medi-Solve is pleased to collaborate with BASF, a world leader in antimicrobial technology," said Ron Sahatjian, Ph.D, President and CEO of Medi-Solve Coatings. Medi-Solve Coatings will be using its proprietary and patented coating technology to apply BASF’s HyGentic® antimicrobial additives to dialysis catheters, PICC lines and other catheters known to have high infection rates in clinical applications. This collaboration benefits clinicians and patients around the world by reducing possible sources of infection and improving the standard of care."
Visit BASF in booth 349 and Medi-Solve in booth 1896 at MD&M West in Anaheim, CA, Feb. 8-10, 2011.